Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Disc MedicineIRON -1.41%35 EV-to-OCF is -12.03 as of Aug. 16, 2026. GuruFocus rates IRON with a GF Score™ of 35/100. The stock has 3 warning signs investors should review. Among 1,410 Biotechnology companies, Disc Medicine ranks better than 73.48% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Disc Medicine's Enterprise Value is $2,377.30 Mil.
Disc Medicine's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $-197.54 Mil. Therefore, Disc Medicine's EV-to-OCF for today is -12.03.
The historical rank and industry rank for Disc Medicine's EV-to-OCF or its related term are showing as below:
IRON'
s EV-to-OCF Range Over the Past 10 Years
Min: -12.03 Med: 0 Max: -12.03
Current: -12.03
During the past 6 years, the highest EV-to-OCF of Disc Medicine was -12.03. The lowest was -12.03. And the median was .
IRON's EV-to-OCF is ranked better than 73.48% of 1410
companies
in the Biotechnology industry
Industry Median: -3.52
vs IRON: -12.03
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Disc Medicine's PE Ratio (TTM) for today is calculated as:
Disc Medicine's share price for today is $79.03.
Disc Medicine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.580.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Disc Medicine EV-to-OCF Related Terms
Disc Medicine EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Disc Medicine's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Disc Medicine's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Disc Medicine EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Disc Medicine's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Disc Medicine's EV-to-OCF falls into.
Disc Medicine's current Enterprise Value is $2,377.30 Mil.
Disc Medicine's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-197.54 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Disc Medicine (IRON) has a EV-to-OCF of -12.03 as of Aug. 16, 2026. According to the industry distribution chart, Disc Medicine ranks #374 out of 1410 companies in the Biotechnology industry, placing it in the top 26.5%.
Is Disc Medicine's EV-to-OCF too high?
Disc Medicine's current EV-to-OCF is -12.03. Based on the distribution chart, Disc Medicine ranks #374 out of 1410 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Disc Medicine has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Disc Medicine's EV-to-OCF compare to CLDX and MBX?
According to the Biotechnology industry distribution chart, Disc Medicine ranks #374 out of 1410 companies for EV-to-OCF. This puts Disc Medicine in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Disc Medicine's current EV-to-OCF is -12.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Disc Medicine stock overvalued right now?
Disc Medicine (IRON) has a current EV-to-OCF of -12.03. The current EV-to-OCF is -12.03. Disc Medicine's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Disc Medicine (IRON), the current EV-to-OCF is -12.03 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
35GF Score
Get the complete analysis for IRON
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRON has been successfully added to your 
